Conference attendance
Pharming Group to participate in March investor conference
Pharming Group N.V. announces that Pharming’s management will participate in the following investor conference in the month of March:
- 37th Annual Roth Conference, Dana Point, CA, USA, March 16-18, 2025
Anurag Relan, Chief Medical Officer, and Michael Levitan, VP Investor Relations and Corporate Communications, will participate in a fireside chat question and answer session on Monday, March 17 at 01:30pm PT/21:30 CET.
For more information about this conference, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Roth representative.